Subscribe Now!

Ultimate Guide to CRAMS or CDMO with various Companies to Track

-
Ultimate Guide to CRAMS or CDMO  with various Companies to track
Twitter Handle: @shuchi_nahar
What are CRAMS?

CRAMS is defined as the process of outsourcing research services/ product manufacturing activities to organizations which can provide the service at a low cost. CRAMS basically consists of the following two activities: Contract Research and Contract Manufacturing. CRAMS is mainly used in the Pharmaceutical and Biotechnology sectors that require extensive R&D and large-scale manufacturing facilities. It is expected that the demand for contract research and contract manufacturing is expected to increase in India in the future.

Roadmap Ahead

Investments in the global pharmaceuticals sector to increase to over $1,400 billion over the next 3 years, driven by a number of new medicines. With healthy R&D spending going forward, the Contract Research and Manufacturing (CRAMS) segment offers growth opportunities to Indian companies.

Rising demand for generic formulations, increased investments in pharmaceutical Research & Development and advanced manufacturing technologies by contract development and manufacturing organization (CDMO’s) are key factors contributing to the high CAGR of Pharmaceutical Contract Manufacturing market during the forecast period.

Market Size – USD 82430.9 Million in 2018, Market Growth – CAGR of 7.2 %, Market Trends – Increasing outsourcing of clinical trials, increasing CDMO’s manufacturing footprint in Asia. The pharmaceutical industry uses outsourcing services from providers in the form of contract research organizations (CROs) and contract manufacturing organizations (CMOs). Comprehensive single-source provider from drug development through commercial manufacture has emerged in recent years.

It is known as contract research and manufacturing services (CRAMS), or contract development and manufacturing organizations (CDMO). Pharmaceutical Contract Manufacturing organizations are a response to the competitive international nature of the pharmaceutical market as well as the increasing demand for outsourced services.

Let’s Discuss in Nutshell Few Companies that I have covered in detail previously in my blogs.

1) Laurus Labs –The Complete Turnaround Story

Laurus Labs is a leading R&D driven pharmaceuticals company established in 2005 with its headquarters in Hyderabad. It is among the leaders in the manufacturing of Active Pharmaceutical Ingredients (APIs) for Antiretroviral (ARV) and Hepatitis C (Hep-C) formulations. Other major API segments include therapeutic areas such as Oncology, Cardiovascular, and Anti-Diabetes.

From a one-product company in 2010 to an Active Pharmaceutical Ingredients (APIs) company thereafter, company has now emerged as one of India’s leading manufacturers of generics APIs for various complex therapies.

Revenue Comparison FY19 v/s FY20


Significant Growth in CDMO





Established in 1988, Hikal is predominantly a B2B player that provides intermediates and active ingredients to global pharmaceutical, animal health, crop protection and specialty chemical companies. 

For FY20, pharma and crop protection accounted for 59% and 41%, respectively, of operating revenues.
The pharma business is currently divided almost equally between generic active pharma ingredients (APIs) and contract development and manufacturing organisation (CDMO) businesses.

Animal health business accounts for 20-25% of CDMO business. In crop protection, 70% of revenues are derived from CDMO with the remaining from proprietary products, specialty chemicals and specialty biocides. Leading Sustainable Technology driven company serving the Crop Protection & Pharmaceutical Industries.

Company’s Crop Protection CDMO segment has 2-3 products in the pipeline currently. These are all early stage products. Overall, product pipeline is healthy.

Revenue Growth Trend over the Years



To continue reading this great compilation of CDMO Companies Click the Link : https://drive.google.com/file/d/1JCvMp0w4syVePB5jnmJsPGvsbSpyReZm/view?usp=sharing

Disclaimer: The information provided on Shuchi Nahar’s Weekend Blog is for educational purposes only. The articles  may contain external links , references and compilation of various publicly available articles. Hence all the authors are given due credit for the same. All copyrights and trademarks of images belong to their respective owners and are used for Fair Educational Purpose only.

Twitter Handle: @shuchi_nahar

Comments

  1. Integrated Drug Discovery Services and IncubatorApril 19, 2022 at 5:25 PM

    I read your blog. contract research organization (CRO) association that offers clinical preliminary and all the examination support to administrations on an agreement premises to the drug, biotechnology. The provided information is very useful for contract research organization in India. Keep continuing to post further.

    ReplyDelete
  2. Pharma Contractor ManufacturerOctober 24, 2023 at 10:02 AM

    This is a comprehensive and informative overview of the Contract Research and Manufacturing Services (CRAMS) sector, particularly its relevance in the pharmaceutical industry. The discussion on the growth opportunities in the Contract Development and Manufacturing Organization (CDMO) segment is quite intriguing, highlighting the evolving landscape of pharmaceutical outsourcing.

    The insights into companies like Laurus Labs and Hikal, which are actively involved in the CDMO business, provide a clear picture of their growth and diverse offerings. It's evident that the CDMO sector plays a crucial role in meeting the demands of the pharmaceutical market, offering a wide range of services from generic APIs to specialty products.

    The provided links for detailed analysis of these companies will be valuable for those looking to delve deeper into the world of CDMO. Thanks for shedding light on these significant players and the evolving trends in the pharmaceutical contract manufacturing market.

    ReplyDelete
  3. Ikon RemediesJanuary 31, 2024 at 12:10 PM

    Ikon remedies is pharma manufacturer in India with custom formulations ,offers a wide range of psychiatric care products. Our list contains over 1000+ products. Contact us now!

    ReplyDelete

Post a Comment

Most Favorite Reads!

Ethanol - Demand, Production, Opportunities & Production Projections (Part-2)

-
Image
Rapid Increase in Ethanol Production Capacity Twitter Handle: @shuchi_nahar Two Different types of processes  to produce Ethanol To produce 684 crore liters of ethanol by the sugar industry by 2025-26, sugarcane equivalent to 60 LMT of surplus sugar would be diverted to ethanol. In the current sugar season, 2020-21 more than 20 LMT of sugar is estimated to be diverted. To produce 666 crore liters of ethanol/ alcohol from food grains by 2025-26, about 165 LMT of food grains would be utilized. At present damaged food grain availability is around 40 lakh tons in the country. In 2020-21 approximately 20 lakh ton maize is surplus FCI Rice is also sufficient in stock (266 LMT) and it will continue to remain robust as procurement of paddy/rice at MSP continues at expected levels. The country is producing sufficient food grains and sugar to meet the requirement for ethanol. Molasses-based distilleries have also been offered interest subvention to convert them to dual feed, to convert both
Read more

Ethanol - Demand, Market Size, Opportunities & New Goverment Policies (Part-2)

-
Image
Ethanol production capacities, impact on Farmers, and Government Plans Twitter Handle: @shuchi_nahar Ethanol was rarely discussed in the country about 7-8 years ago. But now ethanol has become one of the major priorities of 21st century India. The focus on ethanol is having a better impact on the environment as well as on the lives of farmers. India’s requirement of ethanol for petrol blending will increase from 173 crore liters in 2019-20 to 1,016 crore liters in 2025-26. To enable the rollout of ethanol production across India, ethanol may be supplied from surplus to deficit states based on the requirements to ensure uniform availability of ethanol blends in the country. To achieve the Modi Administration’s E-20 blending goal by ethanol supply year (ESY) (December-November) 2025, India would need to procure approximately 11 billion liters (BL) of ethanol for blending with petroleum. As of November 2021, India’s concentrated ethanol production capacity totaled slightly above 6 bi
Read more

Ethanol - Demand, Market Size, Opportunities & New Goverment Policies (Part-1)

-
Image
Ethanol - The next big tailwind story Twitter Handle: @shuchi_nahar Introduction Ethanol , also called ethyl alcohol, drinking alcohol, or simply alcohol is simple alcohol that is often abbreviated as EtOH. Ethanol production in India is mainly dominated by sugary feedstock, and C-heavy molasses available from sugar mills. Ethanol produced by fermentation of renewable food crops such as sugarcane, maize, wheat, sorghum, beet, and other starches is called bioethanol, and it is the eco-friendly alternative biofuel. The product is primarily used as a solvent in various industries such as: In addition, ethanol is gaining popularity as an efficient alternative fuel. It has significant penetration in the major end-use industries such as automotive, foods and beverages, chemicals, personal care and cosmetics, and pharmaceuticals. According to the reports, the global ethanol market is projected to grow at a robust CAGR of 4.5% to reach USD 117 Billion by the end of 2027. The primary factors fa
Read more

Nutraceuticals - The Next Gem of Healthcare Sector

-
Image
     Nutraceuticals - The Next Gem of Healthcare Sector Shuchi.P.Nahar Twitter: shuchi_nahar What is Nutraceuticals? The term ‘nutraceuticals’ was firstly used in the late 1980s to describe food products that have a medicinal benefit. This fast-growing sector includes functional foods (such as vitamin-enriched products), nutritional supplements, sport drinks, and medically formulated foods.  Nutraceuticals and its Division Figure 1: The diagram showing the various divisions of Nutraceuticals  Scope Nutraceuticals is expected to play a central role in preventative healthcare. The logic seems simple - an ageing population gives rise to lifestyle-related diseases, whose impact can be lessened by making healthier choices earlier in life. This convergence of medicine, food and technology is likely to create a battleground in which food and pharma companies compete for dominance of the sector. Successful companies will have to hit the bullseye in six main areas: technology, product strategy,
Read more

Laurus Labs - Result Update Q4FY21 & Full Year FY21

-
Image
Laurus Labs - Result Update Q4FY21 & Full Year FY21 Twitter Handle: @shuchi_nahar Laurus Labs Limited on 30th April 2021 announced its Q4FY21 and full-year results.  Laurus Lab performed extremely well consecutive in the 4th Quarter of FY21. The company did a robust growth in all three segments. Having a healthy order book for FY 22. Consolidated revenue for the quarter increased by 70% driven by growth in all the divisions. The company has been able to sustain its EBITDA margins, and profitability has also improved to Rs. 297 Crs. for the quarter. Generic API division showcased a robust growth of 61% YoY. Anti Viral segment recorded a robust growth of 70% YoY. Revenue Showcased a healthy growth of 102% YoY. The growth was led by higher LMIC Market volumes and increased volumes from North America and EU Commenced marketing of in-licensed products in the USA to leverage front-end capabilities. Custom Synthesis division recorded a strong growth of 35% YoY. Capacity Expansion – To
Read more